NERV - Minerva Neurosciences, Inc.
7.94
-0.060 -0.756%
Share volume: 354,605
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$8.00
-0.06
-0.01%
Summary score
6%
Profitability
0%
Dept financing
10%
Liquidity
50%
Performance
0%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-17.79%
Return on assets
-6.56%
Return on sales
0%
Return on invested capital
-24.22%
Total debt ratio
34.82%
Debt ratio change over timeo
0%
Current Ratio
12.2%
Quick Ratio
0%
Cash Position Ratio
6.95%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-33.77%
Return on assets
-0.6%
Return on sales
0%
Return on invested capital
-17.66%
Total debt ratio
40.78%
Debt ratio change over timeo
0%
Current Ratio
5.96%
Quick Ratio
0%
Cash Position Ratio
4.47%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-13.98%
Return on assets
-12.4%
Return on sales
0%
Return on invested capital
-32.66%
Total debt ratio
11.04%
Debt ratio change over time
0%
Current Ratio
6.49%
Quick Ratio
0%
Cash Position Ratio
6.05%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | NERV | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -17.79% | 18.71% | 4.67% | -3.65% |
| Return on assets | -6.56% | 3.4% | 3.32% | 3.5% |
| Return on sales | 0% | 24.27% | 25.81% | 31.31% |
| Return on invested capital | -24.22% | 5.38% | 4.17% | 4.99% |
| Profitability | 0% | 94% | 70% | 73% |
| Total debt ratio | 34.82% | 78.91% | 58.54% | 101.15% |
| Debt ratio change over time | 0% | 0% | 10.69% | 52.18% |
| Dept financing | 9% | 20% | 20% | 50% |
| Current Ratio | 5.96% | 1.21% | 1.33% | 2.03% |
| Quick Ratio | 0% | 0.94% | 1.07% | 1.9% |
| Cash Position Ratio | 4.47% | 0.21% | 0.6% | 1.41% |
| Liquididy | 50% | 23% | 29% | 31% |
| Short-term ratios | NERV | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -33.77% | 41.05% | 6.87% | -16.17% |
| Return on assets | -0.6% | 3.67% | 3.13% | 2.71% |
| Return on sales | 0% | 26.16% | 24.75% | 29.9% |
| Return on invested capital | -17.66% | 9.43% | 5.58% | 6.54% |
| Profitability | 0% | 97% | 61% | 61% |
| Total debt ratio | 40.78% | 91.28% | 61.3% | 99.31% |
| Debt ratio change over time | 0% | 0% | 13.89% | -24.55% |
| Dept financing | 10% | 23% | 40% | 25% |
| Current Ratio | 5.96% | 1.21% | 1.33% | 2.03% |
| Quick Ratio | 0% | 0.94% | 1.07% | 1.9% |
| Cash Position Ratio | 4.47% | 0.21% | 0.6% | 1.41% |
| Liquididy | 50% | 19% | 23% | 41% |